Similar articles

• A long-term trial of gemfibrozil in the treatment of hyperlipidaemias.

  Eisalo A, Manninen V. Eisalo A, et al. Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):49-52. doi: 10.1177/00359157760690S213. Proc R Soc Med. 1976. PMID: 798198 Free PMC article. Clinical Trial. No abstract available.
• A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.

  Tuomilehto J, Salonen J, Kuuisto P, Virtamo J, Manninen V, Mälkönen M. Tuomilehto J, et al. Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):38-40. doi: 10.1177/00359157760690S209. Proc R Soc Med. 1976. PMID: 798195 Free PMC article. Clinical Trial.
• Evaluation of increasing doses of gemfibrozil in hyperlipoproteinaemia.

  Lageder H, Irsigler K. Lageder H, et al. Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):71-5. doi: 10.1177/00359157760690S217. Proc R Soc Med. 1976. PMID: 798199 Free PMC article. Clinical Trial. No abstract available.
• Does hypolipidemic therapy prevent coronary heart disease?

  Rifkind BM, Levy RI. Rifkind BM, et al. Cardiovasc Clin. 1974;6(2):1-8. Cardiovasc Clin. 1974. PMID: 4374303 Review. No abstract available.
• Lipid lowering effects on cardiovascular morbidity and mortality. Clinical evidence and therapeutic guidelines.

  Islami Y, Ribeiro LG. Islami Y, et al. Arq Bras Cardiol. 1988 Jul;51(1):43-8. Arq Bras Cardiol. 1988. PMID: 3073735 Review. No abstract available.